EUVIMEDEUVIMED entdecken
Crossref

Structure-Based Drug Design Yields Diarylpyrimidine Derivatives as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors

Zhenzhen Zhou iD, Jie Guo, Xin Li, Jinyuan Wu, Erik De Clercq, Christophe Pannecouque, Peng Zhan iD, Dongwei Kang iD, Xinyong Liu iD

ACS Infectious Diseases · 2025

DOI: 10.1021/acsinfecdis.5c00519 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, 2025. Verfasst von Zhenzhen Zhou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Shandong Key Laboratory of Druggability Optimization and Evaluation for Lead Compounds, Key Laboratory of Chemical…. Hauptthemen laut MEDLINE: Reverse Transcriptase Inhibitors, HIV-1, Drug Design, HIV Reverse Transcriptase. Die Arbeit nennt 25 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Taishan Scholar Project of Shandong Province, Shandong University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reverse Transcriptase InhibitorsHIV-1Drug DesignHIV Reverse TranscriptasePyrimidinesAnti-HIV AgentsHumansMolecular Docking SimulationStructure-Activity RelationshipDrug Resistance, ViralMolecular StructureHIV Infections

Stichwörter der Autor:innen

DAPYsHIV-1NNRTIsdrug resistancefragment hybridization

Substanzen

Reverse Transcriptase InhibitorsHIV Reverse TranscriptasePyrimidinesAnti-HIV Agentsreverse transcriptase, Human immunodeficiency virus 1

Autor:innen und Institutionen

  • Department of Medicinal Chemistry, Shandong Key Laboratory of Druggability Optimization and Evaluation for Lead Compounds, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, C…
  • Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, K.U. Leuven, Herestraat 49 Postbus 1043 (09.A097), B-3000 Leuven, Belgium.
  • China-Belgium Collaborative Research Center for Innovative Antiviral Drugs of Shandong Province, 44 West Culture Road, 250012 Jinan, Shandong, P. R. China.

ORCID-Profile: Zhenzhen Zhou, Peng Zhan, Dongwei Kang, Xinyong Liu

Förderung

  • National Key Research and Development Program of China
  • Taishan Scholar Project of Shandong Province
  • Shandong University
  • National Natural Science Foundation of China
  • Shandong Laboratory Program

Zitieren

APA

Zhou, Z., Guo, J., Li, X., Wu, J., Clercq, E., Pannecouque, C., Zhan, P., Kang, D., & Liu, X. (2025). Structure-Based Drug Design Yields Diarylpyrimidine Derivatives as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.5c00519

Vancouver

Zhou Z, Guo J, Li X, Wu J, Clercq E, Pannecouque C, et al. Structure-Based Drug Design Yields Diarylpyrimidine Derivatives as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors. ACS Infectious Diseases. 2025. doi:10.1021/acsinfecdis.5c00519

BibTeX
@article{Zhou2025,
  author = {Zhou, Zhenzhen and Guo, Jie and Li, Xin and Wu, Jinyuan and Clercq, Erik De and Pannecouque, Christophe and Zhan, Peng and Kang, Dongwei and Liu, Xinyong},
  title = {Structure-Based Drug Design Yields Diarylpyrimidine Derivatives as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors},
  journal = {ACS Infectious Diseases},
  year = {2025},
  doi = {10.1021/acsinfecdis.5c00519}
}
Kostenlos starten →